Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report . Atlanta, Ga: Centers for Disease Control and Prevention; 1997:861-867.
Centers for Disease Control and Prevention. Update: mortality attributable to HIV infection among persons aged
25-44 years—United States, 1996. MMWR Morb Mortal Wkly Rep.1996;45:121-125.
Weinstock HS, Sidhu J, Gwinn M, Karon J, Petersen LR. Trends in HIV seroprevalence among persons attending sexually transmitted
disease clinics in the United States, 1988-1992. J Acquir Immune Defic Syndr Hum Retrovirol.1995;9:514-522.
Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in
economic evaluations of HIV prevention programs. J Acquir Immune Defic Syndr Hum Retrovirol.1998;16:54-62. (In press-anticipated date is April 1998).
Oakley A, Fullerton D, Holland J. Behavioural interventions for HIV/AIDS prevention. AIDS.1995;9:479-486.
Peterman TA, Aral SO. Evaluating behavioral interventions. JAMA.1993;269:2845.
Grosskurth H, Mosha F, Todd J.
et al. Impact of improved treatment of sexually transmitted diseases on HIV
infection in rural Tanzania: randomized controlled trial. Lancet.1995;346:530-536.
Higgins DL, Galavotti C, O'Reilly KR.
et al. Evidence for the effects of HIV antibody counseling and testing on
risk behaviors. JAMA.1991;266:2419-2429.
Wolistky RJ, MacGowan JR, Higgins DL, Jorgensen CM. The effects of HIV counseling and testing on risk-related practices
and help-seeking behavior. AIDS Educ Prev.1997;9(suppl 3):52-67.
Kamb ML, Dillon B, Fishbein M, Willis KL.Project RESPECT Study Group. Quality assurance of HIV prevention counseling in a multi-center randomized
controlled trial. Public Health Rep.1996;111(suppl 1):99-107.
Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity. J Stud Alcohol.1997;58:7-29.
Rotheram-Borus MJ, Koopman C, Haignere C. Reducing HIV risk behaviors among runaway adolescents. JAMA.1991;266:1237-1241.
Schulz KF. Subverting randomization in controlled trials. JAMA.1995;274:1456-1458.
Ajzen I, Fishbein M. Understanding Attitudes and Predicting Behavior. Englewood Cliffs, NJ: Prentice Hall; 1980.
Fishbein M, Bandura A, Triandis HC.
et al. Factors Influencing Behavior and Behavior Change: Final Report—Theorist's
Workshop. Rockville, MD: National Institute of Mental Health; 1992.
Fishbein M, Middlestadt SE, Hitchcock PJ. Using information to change sexually transmitted disease-related behaviors. In: Wasserheit JN, Aral SO, Holmes KK, eds. Research Issues
in Human Behavior and Sexually Transmitted Diseases in the AIDS Era .
Washington, DC: American Society for Microbiology; 1991:243-257.
Centers for Disease Control and Prevention. HIV Counseling, Testing, and Referral Standards and Guidelines. Atlanta, Ga: US Dept of Health and Human Services, Centers for Disease
Control and Prevention; 1994.
Centers for Disease Control and Prevention. Technical guidance on HIV counseling. MMWR Morb Mortal Wkly Rep.1993;42:11-17.
Centers for Disease Control and Prevention. 1993 Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep.1993;42(RR-14):1-102.
Richeart CA, Peterman TA, Zaidi AA, Ransom RL, Wroten JE, Witte JJ. A method for identifying persons at high risk for sexually transmitted
infections. Am J Public Health.1993;83:520-524.
Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated
with estimates of treatment effects in controlled trials. JAMA.1995;273:408-412.
Zeiger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics.1986;42:121-130.
Kelly JA, St Lawrence JS, Hood HV, Brasfield TL. Behavioral intervention to reduce AIDS risk activities. J Consult Clin Psychol.1989;57:60-67.
DiClemente RJ, Wingood GM. A randomized controlled trial of an HIV sexual risk-reduction intervention
for young African-American women. JAMA.1995;274:1271-1276.
Wasserheit JN. Epidemiologic synergy: interrelationships between human immunodeficiency
virus infection and other sexually transmitted diseases. Sex Transm Dis.1992;19:61-77.
Rhodes F, Malotte CK. HIV risk interventions for active drug users. In: Oskamp S, Thompson SC, eds. Understanding and Preventing
HIV Risk Behavior: Safer Sex and Drug Use . Thousand Oaks, Calif: Sage
Publications Inc; 1996:211-214.
Standards of Reporting Trial Groups. A proposal for structured reporting of randomized controlled trials. JAMA.1994; 272:1926-1931.
Lawrence J, Kamb ML, Iatesta M.
et al. and the Project RESPECT Study Group. Additional sources of care for STD clinic patients. In: Program and abstracts of the 11th International Conference on
AIDS; July 7-12, 1996; Vancouver, British Columbia.
Flemming TR, DeMets DL. Surrogate endpoints in clinical trials: are we being misled? Ann Intern Med.1996;125:605-613.
Centers for Disease Control and Prevention. HIV Counseling and Testing in Publicly Funded Sites: 1995 Summary
Report . Atlanta, Ga: US Dept of Health and Human Services, Centers for Disease
Control and Prevention; September 1997.